Discover the latest CEPI news
Keep up-to-date on the latest announcements and updates from CEPI and our global partners.
News
Scientists to test if COVID-19 variant vaccine protects against other coronaviruses
IVI will lead a global research consortium developing a mRNA-based broadly protective coronavirus vaccine candidate.
The Viral Most Wanted
The Retroviruses
Impact story
From the pain of Ebola to the passion to fight Lassa
The Viral Most Wanted
The Hantaviruses
Blog
Bringing the 100 Days Mission to global security leaders
Blog
Global Summit to bolster pandemic preparedness
The Viral Most Wanted
The Poxviruses
News
Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial
Blog
CEPI calls for experts to join its Scientific Advisory Committee
The Viral Most Wanted
The Filoviruses
News
Global consortium plans coordinated human challenge studies in hunt for transmission-blocking coronavirus vaccines
News
New ‘spin freezing’ technique could enhance future mRNA vaccines
News
New research to investigate next generation ‘trans-amplifying’ mRNA vaccines
News
Testing the tests: Scientists seek out best on-the-spot diagnostics for deadly Nipah and Lassa
News
Plant-based ALiCE® technology could shave weeks off vaccine production
Blog
Regionalizing vaccine manufacturing: a path to equitable access
News
CEPI and PAHO collaborate to boost regional preparedness against diseases with epidemic or pandemic potential
The Viral Most Wanted
The Nairoviruses
News
Promising new ‘circRNA’ vaccines explored in CEPI-HMRI collaboration
News
Serum Institute of India joins CEPI global network to boost production of affordable outbreak vaccines
Disease X
DISEASE X - What it is, and what it is not
News
Scientists explore how chrysalis-based ‘living bioreactors’ could accelerate new vaccine production
News
CEPI partners with Lemonex to advance mRNA vaccine delivery against future pandemic threats
The Viral Most Wanted
Matonaviruses and Togaviruses
End Pandemics
New partnership aims to advance vaccine against MERS coronavirus
End Pandemics
CEPI partners with Rwandan-US Akagera Medicines to improve the delivery and accessibility of mRNA vaccines
COVAX
COVID-19 vaccinations shift to regular immunisation as COVAX draws to a close
The Viral Most Wanted
The Paramyxoviruses
The Viral Most Wanted
The Flaviviruses
End Pandemics
CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic or pandemic potential
The Viral Most Wanted
The Arenaviruses
End Pandemics
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X
The Viral Most Wanted
The Viral Most Wanted: The Coronaviruses
The Viral Most Wanted
The Coronaviruses
News
Charles River Laboratories joins CEPI's global vaccine assessment network
End Pandemics
CEPI partners with biotech Jurata Thin Film to create needle-free mRNA vaccines and improve access
Blog
The road to even greater vaccine safety
News
CEPI, IVI and MRC Unit The Gambia partner to bolster clinical research capacity in West Africa to combat regional viral threats
The Viral Most Wanted
The Viral Most Wanted: The Arenavirus Family
Blog
Accelerating access to the world's first Chikungunya vaccine
News